Results 21 to 30 of about 11,444,498 (260)

Prevalence of Blood Group A2 in Northern Pakistan

open access: yesPakistan Armed Forces Medical Journal, 2022
Objective: To determine the prevalence of A1 and A2 subgroups of blood group A in healthy blood donors of northern Pakistan. Study Design: Cross sectional study.
Muhammad Sajid Yazdani   +3 more
doaj   +1 more source

Blood Types and Severity of COVID-19 [PDF]

open access: yesEurasian Journal of Family Medicine, 2021
Aim: Since blood types first appeared, their association with diseases caused by microorganisms has been further investigated with several studies for many years.
Burcu Ozdemir   +5 more
doaj   +1 more source

Haematopoietic cell transplantation in Switzerland, changes and results over 20 years: a report from the Swiss Blood Stem Cell Transplantation Working Group for Blood and Marrow Transplantation registry 1997-2016 [PDF]

open access: yes, 2018
In 1997, the Swiss Blood Stem Cell Transplantation Group (SBST) initiated a mandatory national registry for all haematopoietic stem cell transplants (HCTs) in Switzerland.
Bargetzi, M.   +94 more
core   +2 more sources

Expert consensus on the adjustment of whole blood donation interval for voluntary blood donation

open access: yesZhongguo shuxue zazhi
Voluntary blood donation is the cornerstone of safe clinical blood use. In the context of demographic transition and growing healthcare demand, scientifically determining an appropriate whole blood donation interval has become an important strategy for ...
Expert Consensus Writing Group of Adjustment of Whole Blood Donation Interval for Voluntary Blood Donations
doaj   +1 more source

Expert consensus on the adjustment of blood screening strategy for alanine aminotransferase in Chinese blood donors

open access: yesZhongguo shuxue zazhi
Alanine aminotransferase (ALT), as a non-specific alternative test for hepatitis detection, was listed as a mandatory screening item for blood donors in China in the 1990s and has been continued to this day.
Blood Screening Expert Group, National Center for Clinical Laboratories
doaj   +1 more source

Prevalence and distribution of serological characteristics of weak ABO subgroups in the Chinese population

open access: yesHematology, Transfusion and Cell Therapy
Objectives: This study aimed to determine the true frequency of weak ABO subgroups and to investigate the serological characteristics of various subgroup alleles in the Chinese population.
Zhongying Wang   +5 more
doaj   +1 more source

Expert consensus on research of red blood cell transfusion refractoriness

open access: yesZhongguo shuxue zazhi
The incidence of red blood cell transfusion refractoriness (RTR) remains high in clinical practice. The occurrence of RTR not only impairs therapeutic efficacy and increases patients' financial burden, but also leads to the waste of blood resources ...
Expert consensus writing group on ineffective red blood cell transfusion
doaj   +1 more source

Impact of Radiation Therapy on Physical and Psychosocial Health of Adolescents and Young Adults: A Joint Report From the Children's Oncology Group AYA and Radiation Oncology Committees

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Rates of cancer among adolescents and young adults (AYA), age 15–39 years, are increasing. Consequently, radiation oncologists are treating more AYAs who have diagnoses spanning both pediatric and adult practices. Compared to pediatric and older adult patients, AYAs face a unique set of challenges.
Hesham Elhalawani   +7 more
wiley   +1 more source

Nepalese Blood Groups [PDF]

open access: yesNature, 1946
A RECENT tour of duty with the Army in India provided me with an opportunity of testing the blood groups of a number of Gurkha troops, natives of Nepal.
openaire   +2 more sources

Retrospective Analysis of Donor Lymphocyte Infusions in Pediatric Patients With Mixed Chimerism After Hematopoietic Stem Cell Transplantation

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) is an essential therapy for several malignant and nonmalignant diseases, but relapse and graft loss remain the principal threats to its success. Routine monitoring of chimerism and minimal residual disease (MRD) enables early detection of imminent recurrence and guides ...
Carmen Junk   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy